Genomic biomarker detection in East Asian clinical practice using circulating tumour DNA (ctDNA) from patients with gastrointestinal (GI) tract cancers

被引：0
|
作者：
Ikeda, S. [1 ]
Muto, M. [2 ]
Sato, T. [3 ]
Lee, M. [4 ]
Olsen, S. [5 ]
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[2] Kyoto Univ Hosp, Dept Therapeut Oncol, Kyoto, Japan
[3] Utsunomiya Cent Clin, Oncol, Utsunomiya, Tochigi, Japan
[4] Guardant Hlth Pte Ltd, Med Affairs, Singapore, Singapore
[5] Guardant Hlth Pte Ltd, Med & Clin Affairs Dept, Singapore, Singapore
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
310P
引用
收藏
页码：S1363 / S1363
页数：1
相关论文
共 30 条
  • [11] Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA in Routine Clinical Practice
    Dawood, Shaheenah
    Sandhir, Nippun
    Akasheh, Marwan
    El Khoury, Maroun
    Otsmane, Sonia
    Alnassar, Muath
    Abulkhair, Omalkhair
    Farhat, Fadi
    Olsen, Steve
    ONCOLOGY, 2024,
  • [12] Detection of circulating tumor cells in patients with gastrointestinal tract cancer using RT-PCR and its clinical implications
    Yun Hee Noh
    Jung Ah Kim
    G-Rewo Lim
    Young Tae Ro
    Ja Hyun Koo
    Yong Sung Lee
    Dong Soo Han
    Hwon Kyum Park
    Myung Ju Ahn
    Experimental & Molecular Medicine, 2001, 33 : 8 - 14
  • [13] Detection of circulating tumor cells in patients with gastrointestinal tract cancer using RT-PCR and its clinical implications
    Noh, YH
    Kim, JA
    Lim, GR
    Ro, YT
    Koo, JH
    Lee, YS
    Han, DS
    Park, HK
    Ahn, MJ
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2001, 33 (01): : 8 - 14
  • [14] A Pan-Canadian Validation Study for the Detection of EGFR-T790M Mutations Using Circulating Tumour DNA (ctDNA) from Blood
    Selvarajah, S.
    Plante, S.
    Speevak, M.
    Vaags, A.
    Mccready, E.
    Grafodatskaya, D.
    Blais, N.
    Tran-Thanh, D.
    Greer, W.
    Lo, B.
    Demetrick, D.
    Sadikovic, B.
    Walton, R.
    Stockley, T.
    Feilotter, H.
    Joubert, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S206 - S207
  • [15] Minimal residual disease (MRD) detection using a tumour naive circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial
    Day, D.
    Starus, A.
    Gebski, V.
    Simes, J.
    Hayes, T.
    Padinharakam, S.
    Strickland, A. H.
    Briscoe, K.
    Varma, S.
    Barnet, M.
    Jackson, C.
    Horvath, L. G.
    Price, T. J.
    Tebbutt, N.
    Karki, B.
    Diakos, C. I.
    Chia, J.
    Toh, H. C.
    Jones, F. S.
    Segelov, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S426 - S427
  • [16] Utility of circulating tumor DNA (ctDNA) versus tumor tissue clinical sequencing for enrolling patients (Pts) with advanced gastrointestinal (GI) cancer to matched clinical trials: SCRUM-Japan GI-SCREEN and GOZILA Combined Analysis.
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Bando, Hideaki
    Kato, Ken
    Esaki, Taito
    Komatsu, Yoshito
    Takahashi, Naoki
    Ueno, Makoto
    Kagawa, Yoshinori
    Nishina, Tomohiro
    Kato, Takeshi
    Yamamoto, Yoshiyuki
    Furuse, Junji
    Denda, Tadamichi
    Kawakami, Hisato
    Oki, Eiji
    Sunakawa, Yu
    Satoh, Taroh
    Yoshino, Takayuki
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [17] Characterization of circulating tumor free DNA (ctDNA) obtained from patients with metastatic breast carcinoma (MBC) undergoing systemic therapies using comprehensive genomic profiling
    Zhang, Q.
    Gerratana, L.
    Zhang, Y.
    Flaum, L.
    Gradishar, W.
    Platanias, L.
    Cristofanilli, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [18] Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)
    Sherwood, James L.
    Corcoran, Claire
    Brown, Helen
    Sharpe, Alan D.
    Musilova, Milena
    Kohlmann, Alexander
    PLOS ONE, 2016, 11 (02):
  • [19] Landscape of KRAS mutations in non-small cell lung cancer (NSCLC) patients from Asia and Middle East (AME) using circulating tumor DNA (ctDNA)
    Rauthan, A.
    Noronha, V.
    Bharat, R.
    Jain, S. S.
    Olsen, S.
    Joshi, N.
    Prabhash, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S1650 - S1651
  • [20] Utility of circulating tumor DNA (ctDNA) versus tumor tissue clinical sequencing for enrolling patients (pts) with advanced non-colorectal (non-CRC) gastrointestinal (GI) cancer to matched clinical trials: SCRUM-Japan GI-SCREEN and GOZILA combined analysis.
    Ohba, Akihiro
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Ikeda, Masafumi
    Bando, Hideaki
    Mizuno, Nobumasa
    Kato, Ken
    Morizane, Chigusa
    Nishina, Tomohiro
    Ueno, Makoto
    Furuse, Junji
    Hara, Hiroki
    Denda, Tadamichi
    Kawakami, Hisato
    Esaki, Taito
    Moriwaki, Toshikazu
    Yasui, Hisateru
    Komatsu, Yoshito
    Yoshino, Takayuki
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
123